19 articles for L Zeng
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors.

Chinese Academy of Sciences
Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase.

Chinese Academy of Sciences
Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.

Icahn School Of Medicine At Mount Sinai
Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization.

First Affiliated Hospital of Guangzhou Medical University
Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.

Chinese Academy of Sciences
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.

Hangzhou City University
Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment.

Zhejiang University
Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.

Southern Medical University
Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an

Chinese Academy of Sciences
Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.

TBA
The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy.

International Institute For Translational Chinese Medicine
Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.

Chinese Academy of Sciences
Design, synthesis and biological evaluation of benzamide and phenyltetrazole derivatives with amide and urea linkers as BCRP inhibitors.

St. John'S University
Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety.

Xinxiang Medical University
Pyridinamine-pyridone and pyrimidinamine-pyridone compounds

Sprint Bioscience
Inhibitors of IRAK4 activity

Merck Sharp & Dohme
Bifunctional compounds and use for reducing uric acid levels

Acquist
ORA1, a zebrafish olfactory receptor ancestral to all mammalian V1R genes, recognizes 4-hydroxyphenylacetic acid, a putative reproductive pheromone.

German Institute of Human Nutrition Potsdam-Rehbruecke
Chromane compounds

Comentis